Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for CIGNA CORPORATION AND SUBSIDIARIES · Employee benefits company.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 2
 Lobbying activity 3
Health Issues

Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260).

Defense

Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).

Pharmacy

Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem